Showing 3421-3430 of 4062 results for "".
- Vision Expo Organizers Announce New Educational Planning Committee and OptiCon Advisory Board Members for Upcoming Meetingshttps://modernod.com/news/vision-expo-organizers-announce-new-educational-planning-committee-and-opticon-advisory-board-members-for-upcoming-meetings/2480886/The Vision Council and RX—co-organizers of Vision Expo—announced the new Educational Planning Committee and new members of the OptiCon Advisory Board that will oversee the education program for Vision Expo West 2022 and Vision Expo East 2023.
- Haag-Streit to Host 4th Annuel ‘Slit Lamp Imaging Competition’https://modernod.com/news/haag-streit-launches-4th-slit-lamp-imaging-competition/2480876/Haag-Streit announced the launch the "Slit Lamp Imaging Competition 2022." Following successful competitions held in 2019, 2020 and 2021, the competition gives eye care professionals across the globe an opportunity to showcase their slit lamp imaging skills. Judging criteria will i
- New Study Highlights Patient Willingness to Adhere to Pre-Op Prephttps://modernod.com/news/new-study-highlights-patient-willingness-to-adhere-to-pre-op-prep/2480874/Bruder Healthcare announced new research that supports cataract surgeons and comanaging optometrists and ophthalmologists as they help patients prepare for surgery. This noninterventional, cross-sectional investigation of 278 US adults age 65 and older sought to identify cataract s
- Belkin Vision's Automated, Non-Contact Glaucoma Laser Treatment Receives CE Markhttps://modernod.com/news/belkin-visions-eagle-receives-ce-mark-under-mdr/2480859/Israel-based Belkin Vision announced that it has received CE Mark for its Eagle device, making it the first automated, non-contact glaucoma laser treatment available within Europe. The CE Mark was granted under Medical Device Regulation (MDR) from its notified body DEKRA.
- The American Academy of Ophthalmology Commends Congress for Reaching Significant Milestone on Prior Authorization Reform Billhttps://modernod.com/news/the-american-academy-of-ophthalmology-commends-congress-for-reaching-significant-milestone-on-prior-authorization-reform-bill/2480857/The American Academy of Ophthalmology stated that is commends the US House of Representatives for surpassing the 290-cosponsor milestone in support of
- Eyevensys Recaps Highlights from Investigator Meeting and Presentations at ARVOhttps://modernod.com/news/eyevensys-recaps-highlights-from-investigator-meeting-and-presentations-at-arvo/2480854/Eyevensys provided highlights from the Association for Research in Vision and Ophthalmology (ARVO) 2022 Annual Conference in Denver, Colorado. In addition to its participation in the event, Eyevensys also held a successful meeting with principal investigators involved in its clinical trials
- Opthea Data for OPT-302 in Combination With Ranibizumab for PCV Presented at ARVOhttps://modernod.com/news/opthea-data-for-opt-302-in-combination-with-ranibizumab-for-pcv-presented-at-arvo-2022/2480848/Opthea announced that clinical data was presented at the Association for Research in Vision and Ophthalmology (ARVO) 2022 Annual Meeting. The presentation, titled “Efficacy and Safety of OPT-302 in combination with Ranibizumab for Polypoidal Choroidal Vasculopathy,” was held
- Kala Pharmaceuticals Announces New Commercial and Medicare Coverage for Eysuvishttps://modernod.com/news/kala-pharmaceuticals-announces-new-commercial-and-medicare-coverage-for-eysuvis/2480834/Kala Pharmaceuticals announced that the largest Pharmacy Benefit Manager in the United States has added Eysuvis (loteprednol etabonate ophthalmic suspension) 0.25% as a covered brand on its commercial formularies, effective May 1, 2022. This adds 28.5 million people to Eysuvis coverage,
- Funding Awarded to Ophthalmologists Using Big Data to Improve Patient Carehttps://modernod.com/news/funding-awarded-to-ophthalmologists-using-big-data-to-improve-patient-care/2480828/The American Academy of Ophthalmology announced recipients of the 2021
- Atsena Therapeutics Announces Presentations at ARVO and ASGCThttps://modernod.com/news/atsena-therapeutics-announces-presentations-at-arvo-and-asgct/2480825/Atsena Therapeutics announced that research on two of its next-generation adeno-associated virus (AAV) technologies will be presented at the Association for Research in Vision and Ophthalmology (ARVO) 2022 Annual Meeting, and the American Society of Gene & Cell Therapy (ASGC